- Home
- IGC vs ATCH Comparison
IGC vs ATCH Comparison
Compare IGC & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IGC | ATCH |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8M | 39.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IGC | ATCH |
|---|---|---|
| Price | $0.35 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.13 | N/A |
| AVG Volume (30 Days) | 496.5K | ★ 4.8M |
| Earning Date | 11-17-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,106,000.00 | ★ $12,303,120.00 |
| Revenue This Year | $3.54 | N/A |
| Revenue Next Year | $15.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 80.78 |
| 52 Week Low | $0.25 | $0.14 |
| 52 Week High | $0.50 | $15.27 |
Technical Indicators
Market Signals| Indicator | IGC | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 48.56 |
| Support Level | $0.28 | $0.32 |
| Resistance Level | $0.36 | $0.38 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 86.10 | 56.33 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.